Detalhe da pesquisa
1.
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations.
J Clin Oncol
; 42(10): 1158-1168, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38215358
2.
A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trial.
Blood Adv
; 7(16): 4539-4549, 2023 08 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37171402
3.
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.
J Clin Oncol
; 37(3): 178-189, 2019 01 20.
Artigo
Inglês
| MEDLINE | ID: mdl-30523750
4.
Patient advocate involvement in the design and conduct of breast cancer clinical trials requiring the collection of multiple biopsies.
Res Involv Engagem
; 4: 22, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30026963